TARA
Protara Therapeutics Inc
NASDAQ: TARA · HEALTHCARE · BIOTECHNOLOGY
$5.33
+3.09% today
Updated 2026-04-30
Market cap
$273.67M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$3 – $8
Volume
1.0M
Protara Therapeutics Inc (TARA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $7.78M | $5.66M | $84.80M | $67.54M | $43.52M | $43.98M | $23.52M | $6.97M | $203.16M | $172.60M | $113.29M | $78.95M | $181.45M |
| Cash & equivalents | $2.41M | $2.83M | $68.84M | $40.03M | $36.39M | $21.17M | $19.37M | $6.18M | $168.60M | $35.72M | $24.13M | $39.59M | $162.80M |
| Current assets | $7.70M | $5.33M | $84.60M | $66.61M | $42.76M | $43.48M | $23.24M | $6.97M | $169.44M | $93.11M | $86.15M | $68.70M | $172.16M |
| Total liabilities | $4.15M | $9.77M | $2.34M | $4.13M | $5.08M | $9.24M | $3.08M | $583000.00 | $3.91M | $10.68M | $11.21M | $10.63M | $14.32M |
| Current liabilities | $1.20M | $9.77M | $2.34M | $4.13M | $5.08M | $9.24M | $3.08M | $583000.00 | $2.92M | $4.30M | $5.74M | $6.15M | $10.96M |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shareholder equity | $3.63M | $-4.11M | $82.46M | $63.41M | $38.44M | $34.74M | $20.44M | $6.39M | $199.24M | $161.91M | $102.08M | $68.32M | $167.13M |
| Retained earnings | $-86.66M | $-100.51M | $-109.87M | $-131.25M | $-159.78M | $-189.74M | $-210.47M | $-225.46M | $-46.76M | $-94.01M | $-159.96M | $-200.38M | $-244.98M |
| Accounts receivable | — | — | — | $706000.00 | — | — | — | — | — | $634000.00 | $486000.00 | $242000.00 | — |
| Inventory | — | — | — | — | — | — | — | — | — | $1.22M | $1.16M | — | — |
| Goodwill | — | — | — | — | — | — | — | — | $29.52M | $29.52M | $0.00 | — | — |